OUTCOME OF EXTENDED CURETTAGE WITH CEMENTOPLASTY FOR TREATMENT OF GIANT CELL TUMOR OF THE BONE (GCTB) AROUND THE KNEE JOINT (KJ)
Main Article Content
Keywords
Giant cell tumor, knee joint, extended curettage, cementoplasty, musculoskeletal tumor society score, local tumor control, recurrence
Abstract
Introduction: Giant Cell Tumor of the Bone (GCTB) around the Knee Joint poses challenges in management, particularly in the prime working-age population. This study aims to comprehensively analyze the outcomes of Extended Curettage with Cementoplasty, focusing on patient demographics, surgical interventions, joint function, local tumor control, and recurrence rates.
Methodology: Our research study assessed the outcomes of Extended Curettage with Cementoplasty for GCTB around the Knee Joint in 50 patients from Januray 2020 to August 2023 in Orthopedic department of National Institute of Rehabalitation Medecine Islamabad - Pakistan. Data included demographics, tumor characteristics, surgical details, and functional scores. Joint function was evaluated using MSTS scores, while recurrence was monitored at intervals. Statistical analysis was done in SPSS.
Results: A diverse age distribution (36-45 age group, 35%) and gender balance enhance the study's applicability. Extensive curettage with Polymethylmethacrylate (PMMA) augmentation (85%) correlates positively with Musculoskeletal Tumor Society (MSTS) scores. Statistical analysis reveals a significant difference (p=0.037) in MSTS scores between extensive curettage and PMMA augmentation groups. Significant improvement (28%) in joint function, especially in MSTS scores (75%), is attributed to extensive curettage and PMMA's stabilizing effects. A paired t-test shows statistical significance (p=0.005). A commendable 92% success in local tumor control substantiates the effectiveness of Extended Curettage with Cementoplasty. Chi-squared test confirms a significant difference (p=0.02) in control rates. Low recurrence rate (8%) at intervals (6, 12, 18 months) emphasizes the long-term efficacy of the intervention.
Conclusion: Extended Curettage with Cementoplasty emerges as an effective strategy for GCTB around the Knee Joint, showcasing positive outcomes in joint function, local tumor control, and recurrence rates. Tailored surgical interventions play a crucial role in achieving optimal functional recovery. These findings contribute valuable insights to the evolving landscape of GCTB management.
References
2. Verrecchia F, Rédini F. Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment. Front Oncol 2018;8. https://doi.org/10.3389/fonc.2018.00133.
3. De Salvo S, Pavone V, Coco S, Dell’Agli E, Blatti C, Testa G. Benign Bone Tumors: An Overview of What We Know Today. J Clin Med 2022;11:699.
https://doi.org/10.3390/jcm11030699.
4. Anderson WJ, Doyle LA. Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours. Histopathology 2021;78:644–57.
https://doi.org/10.1111/his.14265.
5. Steeg PS. Targeting metastasis. Nat Rev Cancer 2016;16:201–18.
https://doi.org/10.1038/nrc.2016. 25.
6. Whelan JS, Davis LE. Osteosarcoma, Chondrosarcoma, and Chordoma. Journal of Clinical Oncology 2018;36:188–93. https://doi.org/10.1200/JCO.2017.75.1743.
7. Zakaria HM, Llaniguez JT, Telemi E, Chuang M, Abouelleil M, Wilkinson B, et al. Sarcopenia Predicts Overall Survival in Patients with Lung, Breast, Prostate, or Myeloma Spine Metastases Undergoing Stereotactic Body Radiation Therapy (SBRT), Independent of Histology. Neurosurgery 2020;86:705–16. https://doi.org/10.1093/neuros/nyz216.
8. van der Heijden L, van de Sande MAJ, Heineken AC, Fiocco M, Nelissen RGHH, Dijkstra PDS. Mid-Term Outcome After Curettage with Polymethylmethacrylate for Giant Cell Tumor Around the Knee: Higher Risk of Radiographic Osteoarthritis? Journal of Bone and Joint Surgery 2013;95:e159. https://doi.org/10.2106/JBJS.M.00066.
9. Gao T, Zou C, Li Y, Jiang Z, Tang X, Song X. A Brief History and Future Prospects of CEST MRI in Clinical Non-Brain Tumor Imaging. Int J Mol Sci 2021;22:11559.
https://doi.org/10.3390/ijms222111559.
10. Araki Y, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Igarashi K, et al. Secondary Osteoarthritis After Curettage and Calcium Phosphate Cementing for Giant-Cell Tumor of Bone Around the Knee Joint. JBJS Open Access 2020;5:e19.00068-e19.00068.
https://doi.org/10.2106/JBJS.OA.19.00068.
11. Ebeid WA, Badr IT, Mesregah MK, Hasan BZ. Incidence and progression of osteoarthritis following curettage and cementation of giant cell tumor of bone around the knee: long-term follow-up. Journal of Orthopaedics and Traumatology 2023;24:11.
https://doi.org/10.1186/s10195-023-00693-8.
12. Tsukamoto S, Mavrogenis AF, Akahane M, Honoki K, Kido A, Tanaka Y, et al. Risk factors of fracture following curettage for bone giant cell tumors of the extremities. BMC Musculoskelet Disord 2022;23:477. https://doi.org/10.1186/s12891-022-05447-x.
13. Wechsler C, Hodel S, Stern C, Laux CJ, Rosskopf AB, Müller DA. Articular degeneration after subchondral cementation for giant cell tumors at the knee. Surg Oncol 2022;44:101817. https://doi.org/10.1016/j.suronc.2022.101817.
14. Fraquet N, Faizon G, Rosset P, Phillipeau J-M, Waast D, Gouin F. Long bones giant cells tumors: Treatment by curretage and cavity filling cementation. Orthopaedics & Traumatology: Surgery & Research 2009;95:402–6. https://doi.org/10.1016/j.otsr.2009.07.004.
15. Caubère A, Harrosch S, Fioravanti M, Curvale G, Rochwerger A, Mattei J-C. Does curettage–cement packing for treating giant cell tumors at the knee lead to osteoarthritis? Orthopaedics & Traumatology: Surgery & Research 2017;103:1075–9.
https://doi.org/10.1016/j.otsr.2017.06.013.
16. van der Heijden L, Dijkstra PDS, Blay J-Y, Gelderblom H. Giant cell tumour of bone in the denosumab era. Eur J Cancer 2017;77:75–83. https://doi.org/10.1016/j.ejca.2017.02.021.
17. Errani C, Ruggieri P, Asenzio MAN, Toscano A, Colangeli S, Rimondi E, et al. Giant cell tumor of the extremity: A review of 349 cases from a single institution. Cancer Treat Rev 2010;36:1–7. https://doi.org/10.1016/j.ctrv.2009.09.002.
18. Zheng K, Yu X-C, Hu Y-C, Wang Z, Wu S-J, Ye Z-M. How to Fill the Cavity after Curettage of Giant Cell Tumors around the Knee? A Multicenter Analysis. Chin Med J (Engl) 2017;130:2541–6. https://doi.org/10.4103/0366-6999.217093.
19. Radev BR, Kase JA, Askew MJ, Weiner SD. Potential for thermal damage to articular cartilage by PMMA reconstruction of a bone cavity following tumor excision: A finite element study. J Biomech 2009;42:1120–6. https://doi.org/10.1016/j.jbiomech.2009.02.005.
20. Wada T, Kaya M, Nagoya S, Kawaguchi S, Isu K, Yamashita T, et al. Complications associated with bone cementing for the treatment of giant cell tumors of bone. Journal of Orthopaedic Science 2002;7:194–8. https://doi.org/10.1007/s007760200033.
21. Gupta SomP, Garg G. Curettage with cement augmentation of large bone defects in giant cell tumors with pathological fractures in lower-extremity long bones. Journal of Orthopaedics and Traumatology 2016;17:239–47. https://doi.org/10.1007/s10195-016-0397-8.
22. Gangi A, Buy X. Percutaneous Bone Tumor Management. Semin Intervent Radiol 2010;27:124–36. https://doi.org/10.1055/s-0030-1253511.
23. Dolan EB, Haugh MG, Tallon D, Casey C, McNamara LM. Heat-shock-induced cellular responses to temperature elevations occurring during orthopaedic cutting. J R Soc Interface 2012;9:3503–13. https://doi.org/10.1098/rsif.2012.0520.
24. Fröschle GW, Mählitz J, Langendorff HU, Achilles E, Pollock J, Jungbluth KH. Release of daunorubicin from polymethylmethacrylate for the improvement of the local growth control of bone metastasis animal experiments. Anticancer Res 1997;17:995–1002.
25. Kim Y, Kang HG, Kim JH, Kim S, Lin PP, Kim HS. Closed intramedullary nailing with percutaneous cement augmentation for long bone metastases. Bone Joint J 2016;98-B:703–9. https://doi.org/10.1302/0301-620X.98B5.35312.
26. Balestrino A, Boriani S, Cecchinato R, Parafioriti A, Gambarotti M, Gasbarrini A. Vertebroplasty shows no antitumoral effect on vertebral metastasis: a case-based study on anatomopathological examinations. European Spine Journal 2020;29:3157–62. https://doi.org/10.1007/s00586-020-06555-9.
27. Bhide RP, Barman A, Varghese SM, Chatterjee A, Mammen S, George J, et al. A Rare Presentation of Subacute Progressive Ascending Myelopathy Secondary to Cement Leakage in Percutaneous Vertebroplasty. Am J Phys Med Rehabil 2014;93:431–6.
https://doi.org/10.1097/PHM.0000000000000028.
28. Ramanathan S, Vora T, Gulia A, Mahajan A, Desai S. Pulmonary cement embolism in a child following total elbow replacement for primitive neuroectodermal tumour (PNET) of the humerus. Skeletal Radiol 2017;46:715–8. https://doi.org/10.1007/s00256-017-2602-0.
29. Tran I, Gerckens U, Remig J, Zintl G, Textor J. First Report of a Life-Threatening Cardiac Complication After Percutaneous Balloon Kyphoplasty. Spine (Phila Pa 1976) 2013;38:E316–8. https://doi.org/10.1097/BRS.0b013e318281507a.
30. Persson BM, Ekelund L, Lövdahl R, Gunterberg B. Favourable results of acrylic cementation for giant cell tumors. Acta Orthop Scand 1984;55:209–14. https://doi.org/10.3109/17453678 408992339.
31. Dreinhofer K, Rydholm A, Bauer H, Kreicbergs A. Giant-cell tumours with fracture at diagnosis. Curettage and acrylic cementing in ten cases. J Bone Joint Surg Br 1995;77-B:189–93. https://doi.org/10.1302/0301-620X.77B2.7706330.
32. Osman W, Jerbi M, Ben Abdelkrim S, Maaref K, Ben Maitigue M, Ben Ayèche ML. Giant cell tumor of the lower end of tibia. Curettage and cement reconstruction. Foot and Ankle Surgery 2015;21:e16–20. https://doi.org/10.1016/j.fas.2014.09.002.
33. Alkalay D, Kollender Y, Mozes M, Meller I. Giant cell tumors with intraarticular fracture Two-stage local excision, cryosurgery and cementation in 5 patients with distal femoral tumor followed for 2–4 years. Acta Orthop Scand 1996;67:291–4.
https://doi.org/10.3109/17453679608994692.
34. Sahito B, Ali SME, Majid B, Katto MS, Jatoi A, Jahanzeb S. Resultados da curetagem estendida com e sem aloenxerto ósseo para tumores de células gigantes de grau II no joelho. Um estudo comparativo retrospectivo. Rev Bras Ortop (Sao Paulo) 2023;58:141–8. https://doi.org/10.1055/s-0042-1742603.
35. Gupta SomP, Garg G. Curettage with cement augmentation of large bone defects in giant cell tumors with pathological fractures in lower-extremity long bones. Journal of Orthopaedics and Traumatology 2016;17:239–47. https://doi.org/10.1007/s10195-016-0397-8.
36. Gundavda MK, Agarwal MG. Extended Curettage for Giant Cell Tumors of Bone. JBJS Essent Surg Tech 2021;11. https://doi.org/10.2106/JBJS.ST.20.00040.
37. He H, Zeng H, Luo W, Liu Y, Zhang C, Liu Q. Surgical Treatment Options for Giant Cell Tumors of Bone Around the Knee Joint: Extended Curettage or Segmental Resection? Front Oncol 2019;9. https://doi.org/10.3389/fonc.2019.00946.
38. V S, V K. Giant Cell Tumour Around Knee Managed by Curettage and Zoledronic Acid with Structural Support by Fibula Cortical Struts. Malays Orthop J 2020;14:42–9. https://doi.org/10.5704/MOJ.2011.008.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Qaisar Alam
Orthopedic Surgeon, Orthopedic department, National Institute of Rehabilitation Medicine, Islamabad - Pakistan.
Dr Nek Muhammad Khan
Orthopedic Surgeon, Orthopedic department, Khalifa Gul Nawaz Teaching Hospital, Bannu Pakistan
Dr Muhammad Salman
Orthopaedic Surgeon, Zia Darman General Hospital, Mardan - Pakistan
Dr Munib ullah
Orthopedic Surgeon, Orthopedic department, Lady Reading Hospital, Peshawar - Pakistan
Dr Muhammad Fayaz
Orthopedic department, DHQ hospital, Daggar Buner - Pakistan